FOLX BTAC No-Cost Hormone Care

This partnership shows that FOLX was not just selling a telehealth subscription, it was building a financing layer around one of the most durable and underserved care journeys in LGBTQIA health. Hormone therapy is not a one time prescription. It requires an intake visit, regular messaging, lab work, dose adjustments, and ongoing refills. By bundling all of that into a grant, FOLX turned charity dollars into a full care pathway, not a coupon for meds.

• The care fund was structured to cover 12 months of treatment, including clinician visits, messaging, labs, and medication. That matters because the real barrier is often the total process cost and coordination burden, not just the drug itself.
  1 sacra 3 blacktrans
• BTAC gave FOLX trusted distribution into the Black trans community, and the fund reserved 80% of grants for BIPOC recipients. In practice, the nonprofit partner sourced need and trust, while FOLX supplied the clinical operations, pharmacy flow, and virtual follow up.
  2 sacra 3 blacktrans
• This also fits the broader telehealth pattern where higher retention comes from treatments that need ongoing monitoring. Hormone care behaves more like testosterone replacement than one off transactional telehealth, because patients need recurring labs, refills, and dosage changes over time.
  4 sacra 5 folxhealth

The long term implication is that gender affirming care is moving from niche cash pay telehealth into a blended model of insurance, philanthropy, and recurring virtual care. Companies that can combine trusted community access with the machinery to manage visits, labs, prescriptions, and prior authorizations will keep widening their lead.